Table 2.
Clinical and cardiometabolic characteristics of all subjects.
| General characteristics | n = 113 (74 F, 39 M) | ||
| Age (y) | 50 ± 15 | ||
| Height (cm) | 170 ± 10 | ||
| Weight (kg) | 90.1 ± 13.3 | ||
| BMI (kg/m2) | 31.2 ± 2.9 | ||
| Cardiometabolic health | Pre | Post | Change |
| Glucose (mmol/l) | 5.16 ± 0.49 | 5.02 ± 8.8 | −0.12 ± 7.8 ∗ |
| Insulin (pmol/l) | 84.73 ± 44.45 | 55.56 ± 28.47 | −27.78 ± 40.98 ∗ |
| HOMA-IR | 2.85 ± 1.64 | 1.82 ± 1.01 | −0.97 ± 1.47 ∗ |
| Total cholesterol (mmol/l) | 10.46 ± 1.97 | 9.30 ± 1.82 | −0.99 ± 1.24 ∗ |
| Triglycerides (mmol/l) | 6.79 ± 2.89 | 5.55 ± 2.31 | −1.39 ± 2.54 ∗ |
| HDL (mmol/l) | 2.64 ± 0.84 | 2.50 ± 0.61 | 0.01 ± 0.36 |
| LDL (mmol/l) | 6.47 ± 1.74 | 5.68 ± 1.61 | −0.74 ± 0.96 ∗ |
| TC : HDL | 0.24 ± 1.34 | 0.22 ± 1.06 | −0.03 ± 0.75 ∗ |
| Thigh IMAT | |||
| CSA (cm2)¥ | 229.48 ± 47.09 | 212.24 ± 40.31 | −24.46 ± 16.10 ∗ |
| IMATa (cm2) | 11.12 ± 3.46 | 9.84 ± 3.10 | −1.46 ± 1.01 ∗ |
| IMAT | 0.0498 ± 0.0164 | 0.0478 ± 0.0159 | −0.0015 ± 0.0044 ∗ |
| MT (cm2)¥ | 115.55 ± 32.14 | 115.11 ± 30.27 | −3.49 ± 6.92 ∗ |
| SAT (cm2) | 113.71 ± 49.18 | 97.13 ± 42.04 | −20.94 ± 13.58 ∗ |
| Calf IMAT | |||
| CSA (cm2)¥ | 97.68 ± 15.31 | 92.47 ± 14.22 | −5.74 ± 4.64 ∗ |
| IMATa (cm2) | 6.49 ± 2.31 | 5.96 ± 2.29 | −0.63 ± 0.83 ∗ |
| IMAT | 0.0670 ± 0.0229 | 0.0649 ± 0.0238 | −0.0027 ± 0.0073 ∗ |
| MT (cm2)¥ | 61.09 ± 13.26 | 58.67 ± 11.68 | −2.43 ± 2.67 ∗ |
| SAT (cm2) | 36.59 ± 15.29 | 33.44 ± 13.91 | −3.31 ± 2.96 ∗ |
Data are mean ± SD; significance determined through paired t-tests (∗ P values < 0.05). CSA: cross-sectional area of the segment; HDL: high-density lipoprotein; HOMA-IR: homeostatic model assessment of insulin resistance; IMAT: intermuscular adipose tissue (standardized to cross-sectional area); IMATa: intermuscular adipose tissue (absolute quantity); LDL: low-density lipoprotein; MT: muscle tissue; SAT: subcutaneous adipose tissue; TC: total cholesterol; TG: triglyceride. ¥Bone area removed.